Singapore Markets open in 5 hrs 58 mins
Straits Times Index
3,257.18 -5.36 (-0.16%) S&P 500
4,046.80 +18.99 (+0.47%) Dow
32,827.46 +109.86 (+0.34%) Nasdaq
12,000.28 +74.04 (+0.62%) BTC-USD
27,897.86 -432.19 (-1.53%) CMC Crypto 200
608.31 -10.93 (-1.76%)
SpringWorks Therapeutics, Inc. (SWTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:00PM EDT. Market open.
| Previous close | 25.29 |
| Open | 25.36 |
| Bid | 25.78 x 800 |
| Ask | 25.80 x 1000 |
| Day's range | 24.90 - 25.85 |
| 52-week range | 13.60 - 62.40 |
| Volume | |
| Avg. volume | 728,921 |
| Market cap | 1.608B |
| Beta (5Y monthly) | 0.63 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.21 |
| Earnings date | 03 May 2023 - 08 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 65.33 |
- Zacks
SpringWorks (SWTX) Down Despite Desmoid Tumors Study Meeting Goal
SpringWorks' (SWTX) phase III study evaluating its investigational candidate, nirogacestat, in adult patients with progressing desmoid tumors, meets primary and key secondary endpoints.
© 2023 Yahoo. All rights reserved.
